1. [1] Mahdavi, M.; Dianat, S.; Khavari, B.; Moghimi, S.; Abdollahi, M.; Safavi, M.; Mouradzadegun, A.; Kabudanian Ardestani, S.; Sabourian, R.; Emami, S. Synthesis and biological evaluation of novel imidazopyrimidin-3-amines as anticancer agents, Chem. Biol. Drug Des., Volume 89 (2017), pp. 797-805
2. [2] Gryshchenko, A.; Bdzhola, V.; Balanda, A.; Briukhovetska, N.; Kotey, I.; Golub, A.; Ruban, T.; Lukash, L.; Yarmoluk, S. Design, synthesis and biological evaluation of N-phenylthieno [2, 3-d] pyrimidin-4-amines as inhibitors of FGFR1, Biorg. Med. Chem., Volume 23 (2015), pp. 2287-2293
3. [3] French, K. J.; Zhuang, Y.; Maines, L. W.; Gao, P.; Wang, W.; Beljanski, V.; Upson, J. J.; Green, C. L.; Keller, S. N.; Smith, C. D. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2, J. Pharmacol. Exp. Ther., Volume 333 (2010), pp. 129-139
4. [4] Stella, K.; Lynch, F.; Ma, X.; Lee, W.; Hoppin, J.; Christensen, C.; Andreotti, G.; Freeman, L.; Rusiecki, J.; Hou, L. Heterocyclic aromatic amine pesticide use and human cancer risk: results from the US Agricultural Health Study, Int. J. Cancer, Volume 124 (2009), pp. 1206-1212
5. [5] Pflum, D. A.; Krishnamurthy, D.; Han, Z.; Wald, S. A.; Senanayake, C. H. Asymmetric synthesis of cetirizine dihydrochloride, Tetrahedron Lett., Volume 43 (2002), pp. 923-926